163 related articles for article (PubMed ID: 29730853)
1. RenalGuard system to prevent contrast-induced acute kidney injury in Japanese patients with renal dysfunction; RESPECT KIDNEY study.
Katoh H; Nozue T; Horie K; Sozu T; Inoue N; Michishita I
Cardiovasc Interv Ther; 2019 Apr; 34(2):105-112. PubMed ID: 29730853
[TBL] [Abstract][Full Text] [Related]
2. Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
Briguori C; Visconti G; Ricciardelli B; Condorelli G;
EuroIntervention; 2011 Apr; 6(9):1117-22, 7. PubMed ID: 21518686
[TBL] [Abstract][Full Text] [Related]
3. RenalGuard system in high-risk patients for contrast-induced acute kidney injury.
Briguori C; Visconti G; Donahue M; De Micco F; Focaccio A; Golia B; Signoriello G; Ciardiello C; Donnarumma E; Condorelli G
Am Heart J; 2016 Mar; 173():67-76. PubMed ID: 26920598
[TBL] [Abstract][Full Text] [Related]
4. Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury.
Briguori C; Visconti G; Focaccio A; Airoldi F; Valgimigli M; Sangiorgi GM; Golia B; Ricciardelli B; Condorelli G;
Circulation; 2011 Sep; 124(11):1260-9. PubMed ID: 21844075
[TBL] [Abstract][Full Text] [Related]
5. Renal insufficiency following contrast media administration trial III: Urine flow rate-guided versus left-ventricular end-diastolic pressure-guided hydration in high-risk patients for contrast-induced acute kidney injury. Rationale and design.
Briguori C; D'Amore C; De Micco F; Signore N; Esposito G; Napolitano G; Focaccio A;
Catheter Cardiovasc Interv; 2020 Apr; 95(5):895-903. PubMed ID: 31282129
[TBL] [Abstract][Full Text] [Related]
6. Renalguard system in high-risk patients for contrast-induced acute kidney injury.
Briguori C
Minerva Cardioangiol; 2012 Jun; 60(3):291-7. PubMed ID: 22653043
[TBL] [Abstract][Full Text] [Related]
7. Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation).
Barbanti M; Gulino S; Capranzano P; Immè S; Sgroi C; Tamburino C; Ohno Y; Attizzani GF; Patanè M; Sicuso R; Pilato G; Di Landro A; Todaro D; Di Simone E; Picci A; Giannetto G; Costa G; Deste W; Giannazzo D; Grasso C; Capodanno D; Tamburino C
JACC Cardiovasc Interv; 2015 Oct; 8(12):1595-604. PubMed ID: 26386766
[TBL] [Abstract][Full Text] [Related]
8. Study Evaluating the Use of RenalGuard to Protect Patients at High Risk of AKI.
Mauler-Wittwer S; Sievert H; Ioppolo AM; Mahfoud F; Carrié D; Lipiecki J; Nickenig G; Fajadet J; Eckert S; Morice MC; Garot P
JACC Cardiovasc Interv; 2022 Aug; 15(16):1639-1648. PubMed ID: 35981838
[TBL] [Abstract][Full Text] [Related]
9. Feasibility study of the RenalGuard™ balanced hydration system: a novel strategy for the prevention of contrast-induced nephropathy in high risk patients.
Dorval JF; Dixon SR; Zelman RB; Davidson CJ; Rudko R; Resnic FS
Int J Cardiol; 2013 Jun; 166(2):482-6. PubMed ID: 22204847
[TBL] [Abstract][Full Text] [Related]
10. [Monocentric experience of the RenalGuard® system to limit post-contrast acute kidney injury in patients at high-risk undergoing interventional coronary procedures].
Elleuch A; Hebbo A; Steinecker M; Bouaouina MS; Alqudwa A; Ghannem M; Poulos N; Aubry P
Ann Cardiol Angeiol (Paris); 2022 Nov; 71(5):283-289. PubMed ID: 36115720
[TBL] [Abstract][Full Text] [Related]
11. Left Ventricular End-Diastolic Pressure Versus Urine Flow Rate-Guided Hydration in Preventing Contrast-Associated Acute Kidney Injury.
Briguori C; D'Amore C; De Micco F; Signore N; Esposito G; Visconti G; Airoldi F; Signoriello G; Focaccio A
JACC Cardiovasc Interv; 2020 Sep; 13(17):2065-2074. PubMed ID: 32912462
[TBL] [Abstract][Full Text] [Related]
12. Prevention of postcontrast acute kidney injury after percutaneous transluminal angioplasty by inducing RenalGuard controlled furosemide forced diuresis with matched hydration: study protocol for a randomised controlled trial.
Bolt LJJ; Sigterman TA; Krasznai AG; Sikkink CJM; Schurink GH; Bouwman LH
BMJ Open; 2018 Oct; 8(9):e021842. PubMed ID: 30287607
[TBL] [Abstract][Full Text] [Related]
13. Renal function-adjusted contrast volume redefines the baseline estimation of contrast-induced acute kidney injury risk in patients undergoing primary percutaneous coronary intervention.
Andò G; de Gregorio C; Morabito G; Trio O; Saporito F; Oreto G
Circ Cardiovasc Interv; 2014 Aug; 7(4):465-72. PubMed ID: 25027519
[TBL] [Abstract][Full Text] [Related]
14. Incidence of contrast-induced acute kidney injury associated with diagnostic or interventional coronary angiography.
Morabito S; Pistolesi V; Benedetti G; Di Roma A; Colantonio R; Mancone M; Sardella G; Cibelli L; Ambrosino M; Polistena F; Pierucci A
J Nephrol; 2012; 25(6):1098-107. PubMed ID: 22383347
[TBL] [Abstract][Full Text] [Related]
15. Contrast-Associated Acute Kidney Injury in Endovascular Thrombectomy Patients With and Without Baseline Renal Impairment.
Diprose WK; Sutherland LJ; Wang MTM; Barber PA
Stroke; 2019 Dec; 50(12):3527-3531. PubMed ID: 31587663
[TBL] [Abstract][Full Text] [Related]
16. RenalGuard system and conventional hydration for preventing contrast-associated acute kidney injury in patients undergoing cardiac interventional procedures: A systematic review and meta-analysis.
Wang Y; Guo Y
Int J Cardiol; 2021 Jun; 333():83-89. PubMed ID: 33662483
[TBL] [Abstract][Full Text] [Related]
17. Coronary artery calcification scores improve contrast-induced nephropathy risk assessment in chronic kidney disease patients.
Osugi N; Suzuki S; Shibata Y; Tatami Y; Harata S; Ota T; Hayashi M; Yasuda Y; Ishii H; Shimizu A; Murohara T
Clin Exp Nephrol; 2017 Jun; 21(3):391-397. PubMed ID: 27339445
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of prophylactic hydration versus no hydration on contrast-induced acute kidney injury.
Jiang Y; Chen M; Zhang Y; Zhang N; Yang H; Yao J; Zhou Y
Coron Artery Dis; 2017 Dec; 28(8):649-657. PubMed ID: 28692484
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single-center, prospective, randomized, double-blind, placebo-controlled trial.
Brueck M; Cengiz H; Hoeltgen R; Wieczorek M; Boedeker RH; Scheibelhut C; Boening A
J Invasive Cardiol; 2013 Jun; 25(6):276-83. PubMed ID: 23735352
[TBL] [Abstract][Full Text] [Related]
20. New strategy of α- and γ-tocopherol to prevent contrast-induced acute kidney injury in chronic kidney disease patients undergoing elective coronary procedures.
Tasanarong A; Vohakiat A; Hutayanon P; Piyayotai D
Nephrol Dial Transplant; 2013 Feb; 28(2):337-44. PubMed ID: 23314316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
